FY2026 Medical Fee Revision to Take Effect June 1st; Notifications to MHLW Start May 7th – Tsugino Jidai

News Highlights

The FY2026 medical fee revision will be implemented starting June 1st. In conjunction with this, notifications to the Ministry of Health, Labour and Welfare will begin on May 7th. Preparations for this revision cycle will impact medium- to long-term management and succession strategies. Furthermore, joining a group to leverage economies of scale for maintaining facility standards and distributing equipment investment burdens, or utilizing tax benefits by transitioning to a specific medical corporation or social medical corporation, can also be considered key issues.

Perspective from M&A Medical Editorial Department

The confirmation that the FY2026 medical fee revision will take effect on June 1st serves as a clear milestone for healthcare institution managers in formulating their next business plans. In particular, the schedule indicating that notifications for the revision will commence on May 7th suggests that the remaining preparation period is limited. From an M&A and business succession perspective, it is necessary to devise a smooth handover strategy to successors, incorporating the changes in revenue structure brought about by this revision. For instance, it is conceivable that clinics with departments whose profitability may decline due to the revision will explore M&A for operational efficiency through group affiliation or diversification into more profitable businesses. Additionally, participation in regional medical collaboration promotion corporations and utilizing tax incentives such as transitioning to a specific medical corporation or social medical corporation are important for broadening business succession options.

Key Issues Indicated by This News

• The medical fee revision, effective June 1st, directly impacts the revenue structure of medical institutions, making a review of business plans urgent.
• The start of notifications on May 7th signifies a short preparation period for addressing the revision, demanding swift decision-making.
• Economies of scale through group affiliation (maintaining facility standards, distributing equipment investment burdens) can be a motivation for M&A, especially for small to medium-sized medical institutions.
• Transitioning to a specific medical corporation or social medical corporation may become a noteworthy strategy in future healthcare institution management as a succession scheme that leverages tax benefits.

Practical Questions Arising from This News

• What specific impact is anticipated on our institution’s revenue from this medical fee revision?
• If considering group affiliation or a change in corporate status through M&A to respond to the revision, what steps are necessary?
• What preparations should be completed by the start of notifications on May 7th?

If You Feel “Should I Consult Too?”

With the effective date of the FY2026 medical fee revision confirmed and the preparation period limited, now is an excellent opportunity to review how your institution’s management strategy and business succession plan can adapt to this revision. In particular, those who are undecided about whether to consider M&A for group affiliation as a measure to cope with changes in revenue structure, or a change in corporate status utilizing tax benefits, should consider consulting with experts. This will be the first step in objectively analyzing your institution’s situation and finding the optimal choice.

M&A Medical (CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency, providing support for the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are accepted with strict confidentiality. Free consultation here